Dr. Liu has been an inventor and an entrepreneur for fourteen years after serving as a medical investigator in academics for over ten years. Dr. Liu has applied 16 and obtained 12 patents in the United States and abroad while the other 4 are pending. One of the patented technologies has been developed with the TechWorld team as a FDA registered medical device, named NasalCare®. When the TechWorld Team first-time brought the NasalCare® product to the North America ECRM Cough & Cold and Allergy Conference in March 2010, this product received the sole “Best New Product” Award.
Dr. Liu has a keen interest in developing cost-effective products for improving life quality of millions of people. When he realized that there was no drug or vaccine for treating or preventing a number of common respiratory infectious diseases, he pioneered nasal irrigation as early as in 1997, which was three years ahead of the current marketing leader in nasal irrigation industry. Due to the true technological advantages offered from Dr. Liu’s invention, NasalCare® product is independently verified as the most safe squeeze-bottle nasal irrigator since it eliminates 99.6% backflow contamination. Currently, NasalCare® is being used by millions of patients worldwide for treating nasal allergy, acute and chronic rhinitis, cold/flu, etc. More and more patients are turning to NasalCare® for improving their life quality in the USA and world.
Prior to funding TechWorld Corporation, Dr. Liu served as the Senior Project Leader at Abbott Laboratories for 6 years. In this role he was responsible for planning and executing pre-clinical studies and conducting early-phase clinical trials to evaluate the safety and effectiveness of anti-infective compounds in adults, children and infants in the US, Mexico and Chile, and to evaluate the vaccine response in infants fed different formulas. Dr. Liu also served as the Seminar Chairman of Ross Products Division of Abbott Laboratories R&D for two years. Prior to this, Dr. Liu was a Research Assistant Professor at Pennsylvania State University and was responsible for conducting laboratory research on the mechanism of action of cancer chemoprevention. Prior to this, Dr. Liu was an Assistant Professor at Shandong University School of Medicine to teach medical students and to conduct epidemiology and cancer prevention studies. Dr. Liu has published 32 peer-reviewed research articles, authored 16 US patents and received more than 20 medical research awards from the national governments, national professional societies, universities and companies. Dr. Liu received his M.D. at Shandong University School of Medicine, and his Ph.D. at Pennsylvania State University.